IO BIOTECH INC (IOBT) Stock Analyst Ratings
NASDAQ:IOBT • US4497781090
0.3605 USD
-0.02 (-5.13%)
At close: Feb 19, 2026
0.3607 USD
+0 (+0.06%)
Pre-Market: 2/20/2026, 5:25:28 AM
ChartMill assigns a Buy % Consensus number of 52% to IOBT. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 1.66. This target is 361.19% above the current price.
- IOBT was analyzed by 10 analysts. The buy percentage consensus is at 52. So analysts seem to be rather neutral about IOBT.
- In the last month the buy percentage fell by 25 points. So the trust of analysts is decreasing.
- IOBT was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-26 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2025-10-22 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-09-30 | TD Cowen | Downgrade | Buy -> Hold |
| 2025-09-29 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2025-08-12 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-04-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-16 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-09-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-03 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-09-03 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-09-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-28 | Piper Sandler | Initiate | Overweight |
| 2023-09-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-15 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-08-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-03-15 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-24 | Morgan Stanley | Maintains | Overweight |
| 2022-11-21 | HC Wainwright & Co. | Initiate | Buy |
| 2021-11-30 | Cowen & Co. | Initiate | Outperform |
| 2021-11-30 | Morgan Stanley | Initiate | Overweight |
| 2021-11-30 | Jefferies | Initiate | Buy |
IO BIOTECH INC / IOBT FAQ
What is the price target for IOBT stock?
10 analysts have analysed IOBT and the average price target is 1.66 USD. This implies a price increase of 361.19% is expected in the next year compared to the current price of 0.3605.
How do analysts rate IO BIOTECH INC (IOBT)?
The consensus rating for IO BIOTECH INC (IOBT) is 52 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
How many analysts cover IO BIOTECH INC (IOBT) stock?
The number of analysts covering IO BIOTECH INC (IOBT) is 10.